Wesam G Ammari

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 3

Top Topics

Coronavirus Disease

Top Venues

Pharmaceuticals (Basel, Switzerland)

Journal of aerosol medicine and pulmonary drug delivery

This page only lists publications with an associated author ORCID identifier.

Publications

Mohamed El-Tanani, Khaled Abdul-Aziz Ahmed, Ashok K Shakya, Wesam G Ammari, Abdel-Elah Al-Shudifat
Phase II, Double-Blinded, Randomized, Placebo-Controlled Clinical Trial Investigating the Efficacy of Mebendazole in the Management of Symptomatic COVID-19 Patients. Pharmaceuticals (Basel, Switzerland) 16 (6) (2023)
Mohamed El-Tanani, Khaled Abdul-Aziz Ahmed, Ashok K Shakya, Wesam G Ammari, Abdel-Elah Al-Shudifat
Phase II, Double-Blinded, Randomized, Placebo-Controlled Clinical Trial Investigating the Efficacy of Mebendazole in the Management of Symptomatic COVID-19 Patients. Pharmaceuticals (Basel, Switzerland) 16 (6) (2023)
Wesam G Ammari, Mark Sanders
Relative Lung and Systemic Bioavailability Along with Oropharyngeal Deposition of Salbutamol Post-Inhalation: A Pharmacokinetic Evaluation of Novel Inhaler Technique Training Gadgets. Journal of aerosol medicine and pulmonary drug delivery 35 (5) (2022)